Skip to main content
. 2019 Mar 27;63(4):e02382-18. doi: 10.1128/AAC.02382-18

FIG 1.

FIG 1

Observed meropenem (top) and nacubactam (bottom) ELF concentrations in the neutropenic lung infection model, compared with human ELF profiles of meropenem (2 g every 8 h, as 1.5-h infusion) and nacubactam (2 g every 8 h, as 1.5-h infusion). Data are presented as mean ± standard deviation.